trastuzumab-pkrb 150 MG Injection [Herzuma]

RxCUI: 2169362
RxNorm name: trastuzumab-pkrb 150 MG Injection [Herzuma]
Display name: trastuzumab-pkrb 150 MG Injection [Herzuma]
Full name: trastuzumab-pkrb 150 MG Injection [Herzuma]
Term type: SBD
Status: DailyMed mapping
Updated: 2026-06-04 23:39:15

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLA	Proprietary name	Proper name	License type	Status	Latest source
761091	Herzuma	trastuzumab-pkrb	351(k) Biosimilar	Rx	2026-06-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
HERZUMA	TRASTUZUMAB	Cephalon, Inc.	ae71c003-883a-4cd8-ad50-e8cc9a54e971	2025-12-22	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 2169362

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
ae71c003-883a-4cd8-ad50-e8cc9a54e971	trastuzumab-pkrb 150 MG Injection [Herzuma]	SBD	14	These highlights do not include all the information needed to use HERZUMA safely and effectively. See full prescribing information for HERZUMA. HERZUMA ® (trastuzumab-pkrb) for injection, for intravenous use Initial U.S. Approval: 2018 HERZUMA (trastuzumab-pkrb) is biosimilar Biosimilar means that the biological product is approved based on data demonstrating that it is highly similar to an FDA-approved biological product, known as a reference product, and that there are no clinically meaningful differences	20251222
ae71c003-883a-4cd8-ad50-e8cc9a54e971	Herzuma 150 MG Injection	PSN	14	These highlights do not include all the information needed to use HERZUMA safely and effectively. See full prescribing information for HERZUMA. HERZUMA ® (trastuzumab-pkrb) for injection, for intravenous use Initial U.S. Approval: 2018 HERZUMA (trastuzumab-pkrb) is biosimilar Biosimilar means that the biological product is approved based on data demonstrating that it is highly similar to an FDA-approved biological product, known as a reference product, and that there are no clinically meaningful differences	20251222
ae71c003-883a-4cd8-ad50-e8cc9a54e971	Herzuma 150 MG Injection	SY	14	These highlights do not include all the information needed to use HERZUMA safely and effectively. See full prescribing information for HERZUMA. HERZUMA ® (trastuzumab-pkrb) for injection, for intravenous use Initial U.S. Approval: 2018 HERZUMA (trastuzumab-pkrb) is biosimilar Biosimilar means that the biological product is approved based on data demonstrating that it is highly similar to an FDA-approved biological product, known as a reference product, and that there are no clinically meaningful differences	20251222